Novartis India Limited on Wednesday said its net profit after calculating other income stood at Rs.13.5 crore during April-June against Rs.14.3 crore in the corresponding period last fiscal.
In a statement, the company said during the period under review, total income from operations grew to Rs.224.1 crore as compared to Rs.208.8 crore during the corresponding quarter of the previous year.
From April-June this year, its core pharmaceuticals business recorded a total income from operations of Rs.168.9 crore as against Rs.150.6 crore in the previous corresponding quarter.
"The Generics business registered total income from operations of Rs.11.2 crore as against Rs.12.3 crore in the previous corresponding period. The Animal Health business registered total income from operations of Rs.24.5 crore as against Rs.23.0 crore in the previous corresponding period," it said.
The Over-The-Counter business recorded total income from operations of Rs.19.5 crore as against Rs.22.8 crore during the months of April-June in 2014.
"During the quarter under review the company recorded a profit from operations of Rs.0.4 crore as compared to a loss from operations of Rs.4 crore during the corresponding quarter of the previous year," it said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
